| 发明名称 |
Targeting opposite strand replication intermediates of hepatitis C virus by RNAi |
| 摘要 |
<p>The invention relates to methods and compositions for modulating hepatitis C virus (HCV) replication through double-stranded RNA-mediated gene silencing (RNAi), wherein the antiviral methods and compositions preferentially target opposite strand replication intermediates of HCV.</p> |
| 申请公布号 |
EP2772541(A3) |
申请公布日期 |
2014.09.24 |
| 申请号 |
EP20140165247 |
申请日期 |
2005.09.26 |
| 申请人 |
ALNYLAM PHARMACEUTICALS INC. |
发明人 |
MCCALLUS, DANIEL E.;GU, BACHUA;PACHUK, CATHERINE J. |
| 分类号 |
A61K31/713;C12N15/113 |
主分类号 |
A61K31/713 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
